共 50 条
- [32] T-cell dysregulation in COVID-19 [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 204 - 210
- [34] HACHIMIJIOGAN TREATMENT IS EFFECTIVE IN THE MANAGEMENT OF INFERTILE WOMEN WITH HYPERPROLACTINEMIA OR BROMOCRIPTINE-RESISTANT HYPERPROLACTINEMIA [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 1989, 17 (3-4): : 225 - 241
- [39] Drug insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (04): : 200 - 210
- [40] Drug Insight: cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women [J]. Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 200 - 210